BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25575469)

  • 1. Antiresorptive therapy in the management of cancer treatment-induced bone loss.
    Garg A; Leitzel K; Ali S; Lipton A
    Curr Osteoporos Rep; 2015 Apr; 13(2):73-7. PubMed ID: 25575469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
    Brufsky AM
    Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL].
    Takahashi S
    Clin Calcium; 2011 Mar; 21(3):447-53. PubMed ID: 21358067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.
    Candelaria-Quintana D; Dayao ZR; Royce ME
    Breast Cancer Res Treat; 2012 Apr; 132(2):355-63. PubMed ID: 21987034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging drugs for the management of cancer treatment induced bone loss.
    Bertoldo F; Pancheri S; Zenari S; Boldini S
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):323-42. PubMed ID: 20377485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.
    Body JJ; Bergmann P; Boonen S; Boutsen Y; Devogelaer JP; Goemaere S; Reginster JY; Rozenberg S; Kaufman JM
    Osteoporos Int; 2007 Nov; 18(11):1439-50. PubMed ID: 17690930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
    Brufsky A
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of side-effects of systemic treatment: bone loss.
    Body JJ
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii180-5. PubMed ID: 20943612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of cancer treatment-induced bone loss.
    Coleman RE; Rathbone E; Brown JE
    Nat Rev Rheumatol; 2013 Jun; 9(6):365-74. PubMed ID: 23507900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-treatment-induced bone loss, part 2.
    Michaud LB; Goodin S
    Am J Health Syst Pharm; 2006 Mar; 63(6):534-46. PubMed ID: 16522890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to prevent chemotherapy-induced bone loss in women with breast cancer.
    Theriault RL
    Clin Breast Cancer; 2005 Feb; 5 Suppl(2):S63-70. PubMed ID: 15807926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bisphosphonates in the adjuvant setting for breast cancer.
    Reeder JG; Brufsky AM
    Oncology (Williston Park); 2010 May; 24(6):462-7, 475. PubMed ID: 20568587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
    Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer treatment-induced bone loss in breast and prostate cancer.
    Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
    J Clin Oncol; 2008 Nov; 26(33):5465-76. PubMed ID: 18955443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis in breast and prostate cancer survivors.
    Hoff AO; Gagel RF
    Oncology (Williston Park); 2005 Apr; 19(5):651-8. PubMed ID: 15945345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy.
    Yaturu S; DjeDjos S; Alferos G; Deprisco C
    Prostate Cancer Prostatic Dis; 2006; 9(1):35-8. PubMed ID: 16276350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?
    Hadji P; Gnant M; Body JJ; Bundred NJ; Brufsky A; Coleman RE; Guise TA; Lipton A; Aapro MS
    Cancer Treat Rev; 2012 Oct; 38(6):798-806. PubMed ID: 22429722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
    Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating the Causes of Spontaneous Rib Fracture After Breast Cancer.
    Harris SR
    Clin Breast Cancer; 2016 Dec; 16(6):431-436. PubMed ID: 27498118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early breast and prostate cancer and clinical outcomes (fracture).
    Chlebowski RT; Tagawa T
    Oncology (Williston Park); 2009 Dec; 23(14 Suppl 5):16-20. PubMed ID: 20128324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.